Featured Jobs
|
Senior Client Service Specialist EPIC RPS
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans MM Daybright Financial
|
|
BPAS
|
|
Independent Retirement
|
|
Pentegra
|
|
Combo Retirement Plan Administrator Strongpoint Partners
|
|
The Pension Source
|
|
Compass
|
|
Retirement Plan Onboarding Specialist Compass
|
|
Mergers & Acquisition Specialist Compass
|
|
BPAS
|
|
Strongpoint Partners
|
|
Attorney - ERISA, Benefits, & PRT Securian Financial Group
|
|
Automotive Industries Trust Funds
|
|
Nova 401(k) Associates
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Measuring How GLP-1 Medications Impact the Total Cost of Care (PDF)
Milliman 
Aug. 19, 2025 11 pages. "This preliminary observational study of real-world data suggests that increased GLP-1 adherence may lower the medical cost of care for an expanding number of chronic conditions; however, this does not offset the cost of the GLP-1 medications.... Although it may be too early to determine the true impacts of GLP-1 and GLP-1/GIP medications on the overall total cost of care, creating the analytic framework to monitor emerging trends can identify potentially actionable opportunities to re-evaluate care intensity for conditions influenced by GLP-1 drugs." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |